A. Cardin

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A. D. Cardin, A D Cardin, Alan D. Cardin, Alan Cardin, Alan D Cardin, A Cardin
Publication record
79 papers · 4,161 citations · H-index 25

PAPERS

ANT-HERPES VIRUS AND CYTOMEGALOVIRUS POLYUREA OLIGOMERS CROSS REFERENCE TO RELATED APPLICATIONS
20170 citationsauthor #1
Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
20068 citationsauthor #3
Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan
200518 citationsauthor #4
Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
200218 citationsauthor #5
Potent inhibition of human immunodeficiency virus by MDL 101028, a novel sulphonic acid polymer.
19959 citationsauthor #7
Potent Inhibition of Herpes Simplex Virus by MDL 101028, a Novel Biphenyl Disulfonic Acid Urea Co-Polymer
19955 citationsauthor #2
The pharmaceutical formulations comprising polytioureaa and a method for their use
19950 citationsauthor #5
Specific interaction of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid with human cellular CD4.
19943 citationsauthor #6
Crystallographic structure of human gamma-thrombin.
199441 citationsauthor #5
Antiherpesvirus- Science cytomegalovirusoligomerer
19930 citationsauthor #1
Identification of a 63-kDa serum protein that binds somatostatin and gastrin-releasing peptide but not bombesin.
19932 citationsauthor #4
Structure of human des(1-45) factor Xa at 2.2 A resolution.
1993349 citationsauthor #8
Narrow poly- and mono-dispersed anionic oligomers, their uses, formulations and methods
19930 citationsauthor #1
Specific inhibition of binding of antistasin and [A103,106,108] antistasin 93–119 to sulfatide (Gal(3‐SO4)β1‐1Cer) by glycosaminoglycans
19924 citationsauthor #5
Heparin binding properties of the carboxyl terminal domain of [A103,106,108] antistasin 93-119.
19926 citationsauthor #5
Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
199269 citationsauthor #3
Process for the preparation of therapeutically useful oligomers
19910 citationsauthor #1
Oligomers anti-herpes virus and cytomegalovirus.
19910 citationsauthor #1
Oligomers, anvaendning from these two Science preparat innehaollande industry.
19910 citationsauthor #1
Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors.
199111 citationsauthor #5
Demonstration that [A103,106,108] antistasin 93-119 inhibits the specific binding of antistasin to sulfatide [Gal(3-SO4)beta 1-1Cer].
19912 citationsauthor #6
Oligomer, its use and preparation
19910 citationsauthor #1
Oligomers, applications and formulations.
19910 citationsauthor #1
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.
19911,039 citationsauthor #3
Molecular design and modeling of protein-heparin interactions.
199166 citationsauthor #1
Oligomers having activity against herpes and zytomegaliviren
19910 citationsauthor #1
Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle.
199125 citationsauthor #1
Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin.
199126 citationsauthor #3
Ghilantens: anticoagulant-antimetastatic proteins from the South American leech, Haementeria ghilianii.
199023 citationsauthor #4
Ghilanten: antimetastatic agent from the South American leeches Haementeria ghilianii.
19900 citationsauthor #1
Amino acid sequence of ghilanten: anticoagulant-antimetastatic principle of the South American leech, Haementeria ghilianii.
199051 citationsauthor #4
Dependence on heparin chain-length of the interaction of heparin with human plasma low density lipoproteins.
19898 citationsauthor #1
Expression of recombinant diaminopimelate epimerase in Escherichia coli. Isolation and inhibition with an irreversible inhibitor.
198928 citationsauthor #5
High-sensitivity amino acid analysis by derivatization with O-phthalaldehyde and 9-fluorenylmethyl chloroformate using fluorescence detection: applications in protein structure determination.
198976 citationsauthor #4
Interaction of Glycosaminoglycans with Lipoproteins a
198926 citationsauthor #1
A heparin which binds to the envelope glycoprotein gp120 inhibits human immunodeficiency virus replication.
198912 citationsauthor #1
Molecular Modeling of Protein‐Glycosaminoglycan Interactions
19891,201 citationsauthor #1
Inhibition of lymphocyte proliferation by synthetic peptides homologous to human plasma apolipoproteins B and E.
198827 citationsauthor #1
Structural properties of the heparin-binding domains of human apolipoprotein E.
19886 citationsauthor #1
Effect of a sustained release formulation of diltiazem on the development of atherosclerosis in cholesterol-fed rabbits.
198723 citationsauthor #2
In vitro processing of rANF7–28‐NH2 by rat kidney homogenates
19873 citationsauthor #3
Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech.
198728 citationsauthor #4
Micro Method for the Detection of Heparin-Binding Proteins and Peptides
19870 citationsauthor #4
The interaction of N-oleylethanolamine with phospholipid bilayers.
198714 citationsauthor #2
Physical-chemical interaction of heparin and human plasma low-density lipoproteins.
198740 citationsauthor #1
Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B.
198792 citationsauthor #5
Circular dichroism and 1H NMR studies of Co2+- and Ni2+-substituted concanavalin A and the lentil and pea lectins.
19878 citationsauthor #5
Interaction of tryptic peptides of apolipoprotein B-100 with dimyristoylphosphatidylcholine.
198611 citationsauthor #1
Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains.
1986106 citationsauthor #1
Effect of trypsin treatment on the heparin- and receptor-binding properties of human plasma low-density lipoproteins.
198614 citationsauthor #1
A dot-blot assay for heparin-binding proteins.
19869 citationsauthor #4
Structural organization of apolipoprotein B-100 of human plasma low density lipoproteins. Comparison to B-48 of chylomicrons and very low density lipoproteins.
198620 citationsauthor #1
Processing of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins.
19860 citationsauthor #1
Nanosecond motions of the single tryptophan residues in apolipoproteins C-I and C-II: a study by oxygen quenching and fluorescence depolarization.
198511 citationsauthor #2
Suppression of lymphocyte activation by plasma lipoproteins: modulation by cell number and type.
198511 citationsauthor #3
Heparin binding to lipoprotein lipase and low density lipoproteins
19858 citationsauthor #4
Isolation and Characterization of Plasma Lipoproteins and Apolipoproteins
198415 citationsauthor #1
Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100.
198419 citationsauthor #1
Visualization of heparin-binding proteins by ligand blotting with 125I-heparin.
198433 citationsauthor #1
Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins.
1984137 citationsauthor #1
Suppression of lymphocyte activation by plasma lipoproteins.
198339 citationsauthor #3
Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of 125I-labeled low-density lipoproteins by combined use of two monoclonal antibodies.
198333 citationsauthor #6
Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B.
198284 citationsauthor #1
Interaction of discoidal complexes of dimyristoyl phosphatidylcholine-cholesterol-apolipoprotein A-I with human plasma high density lipoprotein HDL3
19820 citationsauthor #2
Effects of human plasma apolipoproteins C‐I, C‐II and C‐III on the phase‐transition of sonicated vesicles of dipalmitoylphosphatidylcholine
198210 citationsauthor #1
5-Dimethylaminonaphthalene-1-sulfonyl 3-aminotyrosyl apolipoprotein C-III. Preparation, characterization, and interaction with phospholipid vesicles.
198216 citationsauthor #1
Thermodynamics of Ca2+ association to Co2+ (S1) preincubated apo-concanavalin A.
19815 citationsauthor #1
Lipoprotein Structure and the Mechanism of Action of Lipoprotein Lipase
19801 citationsauthor #8
Incorporation of dipalmitoyl phosphatidycholine into human plasma low density lipoproteins: effects on composition and structure.
198014 citationsauthor #2
Quantitative analyses of calcium-induced spectral changes in extrinsic Cotton effects of cobalt-substituted concanavalin A.
19805 citationsauthor #1
Cadmium-113 nuclear magnetic resonance investigation of metal binding sites in concanavalin A.
198035 citationsauthor #4
Evidence for specific lead-delta-aminolevulinate complex formation by carbon-13 nuclear magnetic resonance spectroscopy.
19795 citationsauthor #3
Time-dependent changes in the intrinsic cotton effects of concanavalin A.
197915 citationsauthor #1
Nature and reactivity of platinum-pyrimidine blues with biomacromolecules.
19787 citationsauthor #2
Cadmium-113 nuclear magnetic resonance studies of metalloproteins. 1. [113Cd]-concanavalin A: a preliminary investigation
197831 citationsauthor #3
Cobalt-concanavalin A. An index of inactive and active conformational states.
19788 citationsauthor #1
Cadmium-113 Fourier transform nuclear magnetic resonance spectroscopy
197578 citationsauthor #1
CARBON-13 NUCLEAR MAGNETIC RESONANCE OF 5-SUBSTITUTED URACILS
19730 citationsauthor #5
Boron-carbon coupling constants. I. 1-Methylpentaborane(9)
197117 citationsauthor #4

TIMELINE

1971 17 citations

1973 0 citations

1975 78 citations

1978 46 citations

1979 20 citations

1980 55 citations

1981 5 citations

1982 110 citations

1983 72 citations

1984 204 citations

1985 30 citations

1986 160 citations

1987 208 citations

1988 33 citations

1989 1,351 citations

1990 74 citations

1991 1,169 citations

1992 79 citations

1993 351 citations

1994 44 citations

1995 14 citations

2002 18 citations

2005 18 citations

2006 8 citations

2017 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT